Original Text: |
    Women must not be pregnant or breast-feeding because, based on the mechanism of action, crizotinib may cause fetal harm when administered during pregnancy; in animal studies, teratogenicity was not evident, but embryotoxic and fetotoxic effects were noted in rats at crizotinib exposures similar to and above those observed in humans at the recommended clinical dose
Disease/Condition: none
Procedure: Pregnancy
Drug: Crizotinib
Biomarker: none
Computable Rule: |
    "Pregnant" OR "Breast-feeding" is True
